| Style | Citing Format |
|---|---|
| MLA | Moghadasi AN. "Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients." Iranian Journal of Public Health, vol. 50, no. 7, 2021, pp. 1513-1514. |
| APA | Moghadasi AN (2021). Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients. Iranian Journal of Public Health, 50(7), 1513-1514. |
| Chicago | Moghadasi AN. "Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients." Iranian Journal of Public Health 50, no. 7 (2021): 1513-1514. |
| Harvard | Moghadasi AN (2021) 'Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients', Iranian Journal of Public Health, 50(7), pp. 1513-1514. |
| Vancouver | Moghadasi AN. Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients. Iranian Journal of Public Health. 2021;50(7):1513-1514. |
| BibTex | @article{ author = {Moghadasi AN}, title = {Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients}, journal = {Iranian Journal of Public Health}, volume = {50}, number = {7}, pages = {1513-1514}, year = {2021} } |
| RIS | TY - JOUR AU - Moghadasi AN TI - Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients JO - Iranian Journal of Public Health VL - 50 IS - 7 SP - 1513 EP - 1514 PY - 2021 ER - |